2005
Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study
Modi W, Scott K, Goedert J, Vlahov D, Buchbinder S, Detels R, Donfield S, O'Brien S, Winkler C. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes & Immunity 2005, 6: 691-698. PMID: 16177829, DOI: 10.1038/sj.gene.6364258.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdultAllelesBlack or African AmericanChemokine CXCL12Chemokines, CXCChildCohort StudiesDisease ProgressionFemaleGene FrequencyHaplotypesHIV InfectionsHIV-1HumansLongitudinal StudiesMaleOdds RatioPolymorphism, Single NucleotideRisk FactorsSurvival AnalysisUnited StatesWhite PeopleConceptsSDF-1 geneCohort studySingle nucleotide polymorphismsAfrican AmericansOnly natural ligandSingle disease outcomesX4 HIV-1HIV-1 infectionAIDS Cohort StudyRisk of infectionMACS cohortDisease outcomeHIV-1Epidemiological studiesSDF-1Significant associationChemokine genesInfectionRs1801157Natural ligandProgressionHaplotype analysisCommon haplotypeCXCR4Cohort
1999
A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use
Inglesby T, Rai R, Astemborski J, Gruskin L, Nelson K, Vlahov D, Thomas D. A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology 1999, 29: 590-596. PMID: 9918940, DOI: 10.1002/hep.510290219.Peer-Reviewed Original ResearchConceptsSerum ALT levelsALT levelsALT valuesDrug usePrior illicit drug useSerum alanine transaminase levelsAlanine transaminase levelsNormal ALT valuesHepatitis C virusIllicit drug useImportant disease outcomesElevated ALTHepatitis CTransaminase levelsInitial visitLiver biopsyVisit variabilityC virusCommunity-based evaluationLiver enzymesDisease outcomeHCVPatientsMore visitsNatural history